We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

A woman who has suffered with sleep apnoea for a decade is finally able to breathe and sleep again thanks to a new implant.

BMI is widely used as a marker of health, but it turns out that it's not all that accurate -- especially for people of color.